<DOC>
	<DOC>NCT00757679</DOC>
	<brief_summary>Evaluation of the antinociceptive effect of 7 weeks of treatment with milnacipran, compared to placebo, in fibromyalgia out-patients</brief_summary>
	<brief_title>Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Milnacipran</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>patient with FMS according to the 1990 ACR criteria patient willing to withdraw from CNSactive therapies commonly used for FMS, including antidepressants, anticonvulsivants, opiates patient willing to discontinue treatment with tender and trigger point injections, joint injections and anesthetics severe psychiatric illness current Major Depressive Episode (MDE) significant risk of suicide history of substance abuse epilepsy myocardial infarction in the past 24 months active cardiac disease congestive heart failure prosthetic heart valve haemodynamically significant valvular heart disease known cardiac rhythm anomalies or conduction abnormalities unstable and uncontrolled arterial hypertension or supine arterial blood pressure over 160/90 mmHg pulmonary dysfunction active liver disease renal impairment documented autoimmune disease current systemic infection active cancer, except basal cell carcinoma or current cancer therapy severe sleep apnoea active peptic ulcer or inflammatory bowel disease (except IBS) unstable endocrine disease pregnancy or breastfeeding concomitant use of non selective MAO inhibitors, MAOA or B inhibitors, tricyclics, tetracyclics, SSRIs, NARIs, SNRIs, epinephrine, norepinephrine, clonidine and related compounds, longacting benzodiazepines concomitant use of oral anticoagulants, anticonvulsants, type Ic antiarrythmics, lithium concomitant use of hypericum and SAMe concomitant use of digitalis preparations regular use of centrallyacting muscle relaxants concomitant use of strong analgesics, including tramadol, codeine or opiates any factor known to affect the HPA axis or autonomic function such as cigarette smoking (regularly over 25 cigarettes a day)</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>